Anondita Medicare Secures MDSAP Certification, Opens Door To Five Global Markets
Anondita Medicare Limited has received the Medical Device Single Audit Program (MDSAP) Certification under ISO 13485:2016 from DQS Medizinprodukte GmbH, a globally recognised certification authority.
The certification allows the company to sell, distribute, and market its products in Australia, Brazil, Canada, Japan, and the United States, providing a unified regulatory pathway into some of the world’s most stringent medical device markets.
The MDSAP certification strengthens Anondita Medicare’s regulatory credibility and international market readiness, particularly in premium and compliance-driven healthcare markets. It is expected to expand export opportunities and improve acceptance among global distributors, institutions, and government procurement agencies.
Anondita Medicare, known for its flagship COBRA brand, manufactures male and female condoms at its own production facility. The company is actively expanding its domestic and international footprint, with initiatives including UN qualification, automation-led capacity enhancement, and patented female condom products.
In the first half of FY26, Anondita Medicare reported revenue of ₹54.10 crore, EBITDA of ₹19.20 crore (margin 35.49%), and PAT of ₹13.02 crore (margin 24.06%), reflecting strong operational performance.
The certification positions Anondita Medicare to scale exports efficiently and strengthens its competitive positioning in global healthcare markets.
